Reports for MINT PHARMACEUTICALS INC

Company Name

MINT PHARMACEUTICALS INC

Totals

Shortage reports

90

Actual shortage: 36 (40%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 54 (60%)

Discontinuation Reports

21

To be discontinued: 0 (0%)
Discontinued: 21 (100%)
Reversed: 0 (0%)

Late reports

12 (11%)

Overdue reports

4 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-CITALOPRAM 40MG TABLET Actual shortage 2020-04-27 2020-04-27 113285
MINT-CITALOPRAM 20MG TABLET Actual shortage 2020-04-27 2020-04-27 113281
MINT-ZOLMITRIPTAN 2.5MG TABLET Actual shortage 2020-04-25 2020-04-25 113199
MINT-PIOGLITAZONE 45MG TABLET Actual shortage 2020-04-25 2020-04-25 113196
MINT-LOSARTAN/HCTZ 50MG 12.5MG TABLET Actual shortage 2020-04-25 2020-04-25 113193
MINT-LOSARTAN 100.0MG TABLET Actual shortage 2020-04-25 2020-04-25 113190
MINT-LOSARTAN 50.0MG TABLET Actual shortage 2020-04-25 2020-04-25 113187
MINT-CIPROFLOX 250MG TABLET Actual shortage 2020-04-25 2020-04-25 113184
MINT-PIOGLITAZONE 15MG TABLET Actual shortage 2019-07-04 2020-04-25 88502
MINT-PIOGLITAZONE 30MG TABLET Actual shortage 2019-10-09 2020-04-25 95924
MINT-LOSARTAN/HCTZ DS 25.0MG 100.0MG TABLET Actual shortage 2019-04-08 2020-04-25 80811
MINT-FENOFIBRATE E 145MG TABLET Actual shortage 2019-04-08 2020-04-25 80782
MINT-ESCITALOPRAM 20MG TABLET Actual shortage 2019-12-09 2020-04-25 100585
MINT-ESCITALOPRAM 10MG TABLET Actual shortage 2019-12-09 2020-04-25 100582
MINT-LOSARTAN/HCTZ 12.5MG 100MG TABLET Actual shortage 2019-04-08 2020-04-09 80808
MINT-CIPROFLOX 500MG TABLET Resolved 2018-07-31 2020-03-21 57055
MINT-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2020-03-09 2020-03-10 108289
MINT-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2020-03-09 2020-03-10 108295
MINT-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2020-03-09 2020-03-10 108298
MINT-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2020-03-09 2020-03-10 108301

Showing 1 to 20 of 90

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-FENOFIBRATE E 145MG TABLET Discontinued 2020-04-25 2020-04-25 113175
MINT-METFORMIN 850MG TABLET Discontinued 2020-03-09 2020-03-10 108292
MINT-ROSUVASTATIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95897
MINT-ROSUVASTATIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95900
MINT-ROSUVASTATIN 20MG TABLET Discontinued 2019-10-09 2019-10-10 95903
MINT-ROSUVASTATIN 40MG TABLET Discontinued 2019-10-09 2019-10-10 95907
MINT-SOLIFENACIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95913
MINT-SOLIFENACIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95916
MINT-METFORMIN 500MG TABLET Discontinued 2019-07-04 2019-07-05 88513
MINT-DORZOLAMIDE/TIMOLOL 5MG 20MG SOLUTION Discontinued 2019-06-04 2019-06-04 85525
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74435
MINT-CLOPIDOGREL Discontinued 2019-02-04 2019-02-05 74442
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58286
MINT-CLOPIDOGREL 75MG TABLET Discontinued 2018-08-16 2018-08-17 58283
MINT-ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13540
MINT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13544
MINT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13553
MINT-RIVASTIGMINE 4.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13565
MINT-RIVASTIGMINE 3MG CAPSULE Discontinued 2017-06-21 2017-07-01 13556
MINT-RIVASTIGMINE 6MG CAPSULE Discontinued 2017-06-21 2017-07-01 13559

Showing 1 to 20 of 21